Government OKs sale of Novartis-produced MF59-adjuvanted flu vaccine

Published: 2010-09-30 06:57:00
Updated: 2010-09-30 06:57:00
Korea’s health authorities gave the green light to Novartis Korea to sell MF59-adjuvanted influenza vaccine for elderly people aged 65 or more.

An adjuvant is an agent that enhances the immune system's response to a vaccine by 2 to 4 times.

Novartis Korea said it has begun local sales of th...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.